A detailed history of Creative Planning transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Creative Planning holds 44,943 shares of MRVI stock, worth $252,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,943
Previous 43,062 4.37%
Holding current value
$252,130
Previous $308,000 21.1%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$6.84 - $9.73 $12,866 - $18,302
1,881 Added 4.37%
44,943 $373,000
Q2 2024

Aug 15, 2024

SELL
$6.87 - $11.34 $8,312 - $13,721
-1,210 Reduced 2.73%
43,062 $308,000
Q1 2024

May 10, 2024

BUY
$5.11 - $8.76 $27,829 - $47,706
5,446 Added 14.03%
44,272 $383,000
Q4 2023

Feb 14, 2024

BUY
$4.7 - $9.87 $52,715 - $110,701
11,216 Added 40.62%
38,826 $254,000
Q3 2023

Nov 16, 2023

BUY
$9.14 - $12.85 $83,768 - $117,770
9,165 Added 49.69%
27,610 $276,000
Q2 2023

Jul 21, 2023

SELL
$12.09 - $15.0 $49,000 - $60,795
-4,053 Reduced 18.01%
18,445 $229,000
Q1 2023

May 15, 2023

BUY
$12.99 - $16.48 $60,559 - $76,829
4,662 Added 26.14%
22,498 $315,000
Q4 2022

Feb 10, 2023

BUY
$12.5 - $24.78 $37,487 - $74,315
2,999 Added 20.21%
17,836 $255,000
Q3 2022

Nov 03, 2022

SELL
$20.6 - $30.37 $1,174 - $1,731
-57 Reduced 0.38%
14,837 $379,000
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $160,884 - $231,476
-6,176 Reduced 29.31%
14,894 $423,000
Q1 2022

May 16, 2022

BUY
$24.46 - $40.92 $515,372 - $862,184
21,070 New
21,070 $743,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.